Report of a hospital neonatal unit outbreak of community-associated methicillin-resistant Staphylococcus aureus

Epidemiology and Infection

Volumn 137, Issue 9, 2009, Pages 1242-1248

  Gould, I M ^a   Girvan, E K ^b   Browning, R A ^c   Mackenzie, F M ^a   Edwards, G F S ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b Scottish MRSA Reference Laboratory   (United Kingdom)

^c NHS GRAMPIAN   (United Kingdom)

Author keywords

CA MRSA; Control; Hospital neonatal outbreak

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ENTEROTOXIN; ERYTHROMYCIN; EXFOLIATIN; FLUCLOXACILLIN; FUSIDATE SODIUM; FUSIDIC ACID; GENTAMICIN; LEUKOCIDIN; LEUKOCIDIN A; LINEZOLID; PSEUDOMONIC ACID; RIFAMPICIN; STAPHYLOCOCCAL CHROMOSOMAL CASSETTE MEC TYPE 4 PROTEIN; TEICOPLANIN; TRICLOSAN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CELL LINEAGE; CESAREAN SECTION; CLINICAL ARTICLE; COMMUNITY ASSOCIATED METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; CONTROLLED STUDY; EPIDEMIC; FEMALE; HOSPITAL INFECTION; HUMAN; LABOR; MALE; MATERNITY WARD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PEDIATRIC WARD; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SKIN INFECTION; SOFT TISSUE INFECTION; UNITED KINGDOM;

ADULT; BACTERIAL PROTEINS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; ELECTROPHORESIS, GEL, PULSED-FIELD; EXFOLIATINS; FEMALE; HUMANS; INFANT, NEWBORN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SCOTLAND; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 69949172067     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809002234     Document Type: Article

References (26)

1. Herold BC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. Journal of the American Medical Association 1998; 279: 593-598.
2. Naimi TS, et al. Comparison of community and healthcare-associated methicillin-resistant Staphylococcus aureus infection. Journal of the American Medical Association 2003; 290: 2976-2984.
3. Centres for Disease Control and Prevention. Four paediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus infections - Minnesota and North Dakota, 1997-1999. Morbidity & Mortality Weekly Report 1999; 48: 707-710.
4. Mongkolrattanothai K, et al. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clinical Infectious Diseases 2003; 37: 1050-1058.
5. Enright MC, et al. Multilocus sequence typing for the characterization of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) clones of Staphylococcus aureus. Journal of Clinical Microbiology 2000; 38: 1008-1015.
6. Bratu S, et al. Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerging Infectious Diseases 2005; 66: 808-813.
7. Saiman L, et al. Hospital transmission of community-acquired methicillin resistant Staphylococcus aureus among postpartum women. Infectious Diseases 2003; 37: 1313-1319.
8. Sax H, et al. Control of a cluster of commuity-associated, methicillin-resisant Staphylococcus aureus in neonatology. Journal of Hospital Infection 2006; 63: 93-100.
9. MacKenzie FM, et al. Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland. Journal of Antimicrobial Chemotherapy 2002; 50: 689-697.
10. Johnson WM, et al. Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin-1 in Staphylococcus aureus by polymerase chain reaction. Journal of Clinical Microbiology 1991; 29: 426-430.
11. Becker K, Roth R, Peters G. Rapid and specific detection of toxigenic Staphylococcus aureus; use of 2 multiplex PCR enzyme immunoassays for amplification and hybridisation of staphylococcal enterotoxin genes, exfoliative genes and toxic shock syndrome toxin-1 gene. Journal of Clinical Microbiology 1998; 36: 2548-2553.
12. Sakurai S, Suzuki H, Machida K. Rapid identification by polymerase chain reaction of staphylococcal exfoliatave toxin serotype A and B genes. Microbiology & Immunology 1995; 39: 379-386.
13. Lina G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29 1128-1132.
14. Brakstad GE, Aasbakk K, Maeland JA. Detection of Staphylococcus aureus by Polymerase Chain Reaction amplification of the nuc gene. Journal of Clinical Microbiology 1992; 30: 1654-1660.
15. Bignardi GE, et al. Detection of the mecA gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low level methicillin resistance. Journal of Antimicrobial Chemotherapy 1996; 37: 53-63.
16. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2002; 46: 2155-2161.
17. Campbell AL, et al. Epidemiology of methicillin-resistant Staphylococcus aureus at a children's hospital. Infection Control & Hospital Epidemiology 2003; 24: 427-430.
18. de Almeida Silva H, et al. Infection and colonisation by Staphylococcus aureus in a high risk nursery of a Brazilian teaching hospital. Brazilian Journal of Infectious Diseases 2003; 7: 381-386.
19. Chambers HF. Community-associated MRSA - resistance and virulence converge. New England Journal of Medicine 2005; 352: 1485-1487.
20. Deresinski S. Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. Clinical Infectious Diseases 2005; 40: 562-573.
21. Fridkin SK, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. New England Journal of Medicine 2005; 352: 1485-1487.
22. Seetulsingh P, Curtis C, Kearns AM. Outbreak of ciprofloxacin-susceptible community-associated methicillin-resistant Staphylococcus aureus in a neonatal unit. Journal of Hospital Infection 2008; 68: 374-375.
23. Otter JA, et al. Identification and control of an outbreak of ciprofloxacin-susceptible EMRSA-15 on a neonatal unit. Journal of Hospital Infection 2007; 67: 232-239.
24. David MD, et al. Community-associated MRSA: Nosocomial transmission in a neonatal unit. Journal of Hospital Infection 2006; 64: 244-250.
25. Ladhani S, et al. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing Staphylococcal Scalded-Skin Syndrome. Clinical Microbiology Reviews 1999; 12: 224-242.
26. Gould IM. Community-acquired MRSA: Can we control it? Lancet 2006; 368: 824-826.